Under construction – not a live service
Sign in

2025-522640-41-00RecruitingPhase 2

A Study to Evaluate Brenipatide Compared with Placebo in Adult Participants with Uncontrolled Moderate to Severe Asthma

J2S-MC-GZMR: A Phase 2, Multicenter, Randomized, Double-blind, 52-week Study, to Investigate the Efficacy and Safety of Brenipatide Compared with Placebo for the Treatment of Adult Participants with Uncontrolled Moderate to Severe Asthma

Source: EU CTIS (euclinicaltrials.eu) · Last updated 26 Aug 2026

Next steps

Brief summary (registry, in English)

To evaluate the efficacy of brenipatide relative to placebo in reducing severe asthma exacerbations

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
137 (estimated)
First submitted
26 Sept 2025
Start date
13 Feb 2026
Lead sponsor
Eli Lilly & Co.
Diseases
Asthma
EU CT number
2025-522640-41-00

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 137
  • 29 sites in 4 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Participants must not have a Lung condition other than asthma, such as smoker’s lung, infections that has been going on for a long time or didn’t go away completely

Other

  • Participants must not have a Diagnosis of job-related asthma

Who the study is looking for

  • Participants must have been diagnosed with asthma and have received an asthma controller medication prescribed by their doctor for at least 12 months prior to screening
  • Participants must have a history of 1 severe asthma exacerbation that led to oral steroid treatment in the last 12 months prior to screening

Age in the registry: 18 years to 64 years · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (29)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
KPPK GmbHBendorfGermanyRecruiting
Studienpraxis Berlin-Brandenburg Cornelia Seelbinder Und Lennart Schaper GbRBerlinGermanyRecruiting
Ruhrlandklinik Westdeutsches Lungenzentrum Am Universitaetsklinikum Essen gGmbHEssenGermanyRecruiting
Universitaetsklinikum Essen (AoR)EssenGermanyRecruiting
IKF Pneumologie GmbH & Co. KGFrankfurt am MainGermanyRecruiting
ME Clinical Respiratory Research Hamburg GmbHHamburgGermanyRecruiting
POIS Sachsen GmbHLeipzigGermanyRecruiting
IKF Pneumologie GmbH & Co. KGMainzGermanyRecruiting
Dedicated Research Site FutureMedsOffenbachGermanyRecruiting
Centre Hospitalier Du Pays D Aix Centre Hospitalier Intercommunal Aix-PertuisAix En ProvenceFranceRecruiting
Centre Hospitalier Régional et Universitaire de BrestBrestFranceRecruiting
Centre Hospitalier de CholetCholetFranceRecruiting
Centre Hospitalier De VersaillesLe Chesnay CedexFranceRecruiting
Assistance Publique Hopitaux De ParisLe Kremlin-BicetreFranceRecruiting
Groupe Hospitalier Intercommunal Le Raincy MontfermeilMontfermeilFranceRecruiting
Assistance Publique Hopitaux De ParisParis Cedex 18FranceRecruiting
Centre Hospitalier Universitaire de BordeauxPessacFranceRecruiting
Centre Hospitalier Universitaire de RennesRennesFranceRecruiting
Hospital FochSuresnesFranceRecruiting
EB FlevoResearch B.V.AlmereNetherlandsRecruiting
Amphia HospitalBredaNetherlandsRecruiting
Canisius Wilhelmina ZiekenhuisNijmegenNetherlandsRecruiting
Sint Franciscus Vlietland Groep StichtingRotterdamNetherlandsRecruiting
Gelre HospitalsZutphenNetherlandsRecruiting
Isala Klinieken StichtingZwolleNetherlandsRecruiting
Centrum Medyczne All-Med Badania KliniczneCracowPolandRecruiting
Diamond Clinic Sp. z o.o.CracowPolandRecruiting
Alergologia Plus sp. z o.o.PoznanPolandRecruiting
Specjalistyczna Przychodnia Lekarska Alergo-Med Sp. z o.oPoznanPolandRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.